دورية أكاديمية
Validating core therapeutic targets for osteoporosis treatment based on integrating network pharmacology and informatics
| العنوان: | Validating core therapeutic targets for osteoporosis treatment based on integrating network pharmacology and informatics |
|---|---|
| المؤلفون: | Shiyang Weng, Huichao Fu, Shengxiang Xu, Jieruo Li |
| المصدر: | SLAS Technology, Vol 29, Iss 2, Pp 100122- (2024) |
| بيانات النشر: | Elsevier, 2024. |
| سنة النشر: | 2024 |
| المجموعة: | LCC:Biotechnology LCC:Medical technology |
| مصطلحات موضوعية: | Osteoporosis, Metabolism-related lncRNAs, TCMSP database, WGCNA, Molecular docking, Biotechnology, TP248.13-248.65, Medical technology, R855-855.5 |
| الوصف: | Objective: Our goal was to find metabolism-related lncRNAs that were associated with osteoporosis (OP) and construct a model for predicting OP progression using these lncRNAs. Methods: The GEO database was employed to obtain gene expression profiles. The WGCNA technique and differential expression analysis were used to identify hypoxia-related lncRNAs. A Lasso regression model was applied to select 25 hypoxia-related genes, from which a classification model was created. Its robust classification performance was confirmed with an area under the ROC curve close to 1, as verified on the validation set. Concurrently, we constructed a ceRNA network based on these genes to unveil potential regulatory processes. Biologically active compounds of STZYD were identified using the Traditional Chinese Medicine System Pharmacology Database and Analysis Platform (TCMSP) database. BATMAN was used to identify its targets, and we obtained OP-related genes from Malacards and DisGeNET, followed by identifying intersection genes with metabolism-related genes. A pharmacological network was then constructed based on the intersecting genes. The pharmacological network was further integrated with the ceRNA network, resulting in the creation of a comprehensive network that encompasses herb-active components, pathways, lncRNAs, miRNAs, and targets. Expression levels of hypoxia-related lncRNAs in mononuclear cells isolated from peripheral blood of OP and normal patients were subsequently validated using quantitative real-time PCR (qRT-PCR). Protein levels of RUNX2 were determined through a western blot assay. Results: CBFB, GLO1, NFKB2 and PIK3CA were identified as central therapeutic targets, and ADD3-AS1, DTX2P1-UPK3BP1-PMS2P11, TTTY1B, ZNNT1 and LINC00623 were identified as core lncRNAs. Conclusions: Our work uncovers a possible therapeutic mechanism for STZYD, providing a potential therapeutic target for OP. In addition, a prediction model of metabolism-related lncRNAs of OP progression was constructed to provide a reference for the diagnosis of OP patients. |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English |
| تدمد: | 2472-6303 |
| Relation: | http://www.sciencedirect.com/science/article/pii/S2472630324000049; https://doaj.org/toc/2472-6303 |
| DOI: | 10.1016/j.slast.2024.100122 |
| URL الوصول: | https://doaj.org/article/71ad62cf1f154b54bdb052dd5abfa0a4 |
| رقم الأكسشن: | edsdoj.71ad62cf1f154b54bdb052dd5abfa0a4 |
| قاعدة البيانات: | Directory of Open Access Journals |
Full Text Finder | تدمد: | 24726303 |
|---|---|
| DOI: | 10.1016/j.slast.2024.100122 |